Company intelligence / Profile preview

Shanghai Huaxia Investment Management

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Shanghai Huaxia Investment Management is a Chinese investment and holding company that focuses on the healthcare, life sciences, and biotechnology sectors. The firm operates primarily as a strategic investor and management entity, overseeing a portfolio of healthcare assets including medical institutions and specialized biotech subsidiaries. One of its most notable holdings is Shanghai Huaxia Gene Pharmaceutical, which specializes in genetic testing, health management, and regenerative medicine. Through its various subsidiaries and strategic investments, the company provides a range of services from clinical diagnostics to hospital management and pharmaceutical distribution.

Industry: Investors

Beyond the preview

Go deeper on Shanghai Huaxia Investment Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Huaxia Investment Management.

Explore the full profile